Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines

M. Zessin, M. Meleshin, S. Hilscher, C. Schiene-Fischer, C. Barinka, M. Jung, M. Schutkowski

. 2023 ; 24 (8) : . [pub] 20230418

Language English Country Switzerland

Document type Journal Article

Grant support
INST 271/336-1 FUGG Deutsche Forschungsgemeinschaft
RVO: 86652036 Czech Academy of Sciences
21-31806 Czech Science Foundation

Lysine deacetylases, like histone deacetylases (HDACs) and sirtuins (SIRTs), are involved in many regulatory processes such as control of metabolic pathways, DNA repair, and stress responses. Besides robust deacetylase activity, sirtuin isoforms SIRT2 and SIRT3 also show demyristoylase activity. Interestingly, most of the inhibitors described so far for SIRT2 are not active if myristoylated substrates are used. Activity assays with myristoylated substrates are either complex because of coupling to enzymatic reactions or time-consuming because of discontinuous assay formats. Here we describe sirtuin substrates enabling direct recording of fluorescence changes in a continuous format. Fluorescence of the fatty acylated substrate is different when compared to the deacylated peptide product. Additionally, the dynamic range of the assay could be improved by the addition of bovine serum albumin, which binds the fatty acylated substrate and quenches its fluorescence. The main advantage of the developed activity assay is the native myristoyl residue at the lysine side chain avoiding artifacts resulting from the modified fatty acyl residues used so far for direct fluorescence-based assays. Due to the extraordinary kinetic constants of the new substrates (KM values in the low nM range, specificity constants between 175,000 and 697,000 M-1s-1) it was possible to reliably determine the IC50 and Ki values for different inhibitors in the presence of only 50 pM of SIRT2 using different microtiter plate formats.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011754
003      
CZ-PrNML
005      
20230801133320.0
007      
ta
008      
230718s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms24087416 $2 doi
035    __
$a (PubMed)37108579
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Zessin, Matthes $u Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany
245    10
$a Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines / $c M. Zessin, M. Meleshin, S. Hilscher, C. Schiene-Fischer, C. Barinka, M. Jung, M. Schutkowski
520    9_
$a Lysine deacetylases, like histone deacetylases (HDACs) and sirtuins (SIRTs), are involved in many regulatory processes such as control of metabolic pathways, DNA repair, and stress responses. Besides robust deacetylase activity, sirtuin isoforms SIRT2 and SIRT3 also show demyristoylase activity. Interestingly, most of the inhibitors described so far for SIRT2 are not active if myristoylated substrates are used. Activity assays with myristoylated substrates are either complex because of coupling to enzymatic reactions or time-consuming because of discontinuous assay formats. Here we describe sirtuin substrates enabling direct recording of fluorescence changes in a continuous format. Fluorescence of the fatty acylated substrate is different when compared to the deacylated peptide product. Additionally, the dynamic range of the assay could be improved by the addition of bovine serum albumin, which binds the fatty acylated substrate and quenches its fluorescence. The main advantage of the developed activity assay is the native myristoyl residue at the lysine side chain avoiding artifacts resulting from the modified fatty acyl residues used so far for direct fluorescence-based assays. Due to the extraordinary kinetic constants of the new substrates (KM values in the low nM range, specificity constants between 175,000 and 697,000 M-1s-1) it was possible to reliably determine the IC50 and Ki values for different inhibitors in the presence of only 50 pM of SIRT2 using different microtiter plate formats.
650    12
$a sirtuiny $x metabolismus $7 D037761
650    _2
$a sirtuin 2 $x metabolismus $7 D056565
650    _2
$a lysin $7 D008239
650    _2
$a sirtuin 1 $x metabolismus $7 D056564
650    12
$a sirtuin 3 $x metabolismus $7 D056566
650    _2
$a peptidy $7 D010455
650    _2
$a barvicí látky $7 D004396
655    _2
$a časopisecké články $7 D016428
700    1_
$a Meleshin, Marat $u Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany
700    1_
$a Hilscher, Sebastian $u Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany
700    1_
$a Schiene-Fischer, Cordelia $u Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany
700    1_
$a Barinka, Cyril $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Prumyslova 595, 25250 Vestec, Czech Republic $1 https://orcid.org/0000000327513060 $7 xx0126049
700    1_
$a Jung, Manfred $u Institute of Pharmaceutical Sciences, University of Freiburg, Albertstraße 25, 79104 Freiburg, Germany $1 https://orcid.org/0000000263617716 $7 ntk20201064928
700    1_
$a Schutkowski, Mike $u Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 24, č. 8 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37108579 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133317 $b ABA008
999    __
$a ok $b bmc $g 1963914 $s 1198019
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 8 $e 20230418 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a INST 271/336-1 FUGG $p Deutsche Forschungsgemeinschaft
GRA    __
$a RVO: 86652036 $p Czech Academy of Sciences
GRA    __
$a 21-31806 $p Czech Science Foundation
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...